Genius Sports price target lowered to $6 from $12 at UBS

UBS lowered the firm’s price target on Genius Sports (GENI) to $6 from $12 and keeps a Neutral rating on the shares. Genius Sports met adjusted EBITDA targets but failed to grow cash flow in 2025, with year-end cash essentially flat excluding its early-2025 equity raise, the analyst tells investors in a research note. The shortfall highlights concerns that its heavily adjusted EBITDA metric may not reflect true cash generation, particularly as costly NFL and EPL rights have yet to translate into meaningful cash flow growth, and the $1.2B Legend acquisition adds further spending not directly tied to monetizing those sports rights, the firm says.